INS and Hyperglycemia: By inhibiting the degradation of incretins, these agents enhance insulin secretion, suppress glucagon release, and reduce postprandial hyperglycemia-dependent oxidative stress, thereby attenuating AGE accumulation and glomerular endothelial dysfunction.